Oral antibacterial effect of chlorhexidine treatments and professional prophylaxis in children

Abstract

AIM: The primary aim of this longitudinal study was to evaluate additional effects of 4-week chlorhexidine digluconate (CHX) gel treatments to control Aggregatibacter actinomycetemcomitans counts in children after professional dental prophylaxis. Porphyromonas gingivalis and Streptococcus mutans counts were also determined to evaluate the secondary effects of anti-plaque treatments on microbial shifts. METHODS: Twenty-six children with A. actinomycetemcomitans counts >4 log10/mL of saliva and/or Quigley-Hein plaque index >3.0 were enrolled in this study. Patients were randomly assigned to groups GI (placebo gel), GII (0.5% CHX gel), GIII (1% CHX gel), and GIV (2% CHX gel). Four sessions of treatment were performed during 4 weeks after a session of professional dental prophylaxis. Real-Time polymerase chain reaction (PCR) was used to determine viable microorganism counts in non-stimulated whole saliva samples collected at baseline, one week, one month and three months after interruption of treatments. RESULTS: A reduction of all bacterial counts was detected after the 3-month follow-up in all groups. Lower counts of P. gingivalis were achieved from 1 week on after treatments. The 2% CHX concentration seemed to contribute to lower A. actinomycetemcomitans levels and increase S. mutans levels. CONCLUSIONS: Professional dental prophylaxis was effective to control salivary levels of A. actinomycetemcomitans, P. gingivalis and S. mutans. Additional antimicrobial effects, however, were not observed by the combination of professional dental prophylaxis and 4-week chlorhexidine gel treatments.

aggressive periodontitis; professional prophylaxis; chlorhexidine; Aggregatibacter actinomycetemcomitans; Porphyromonas gingivalis; Streptococcus mutans

• ¹
  Albandar JM, Buischi YAP, Barbosa MFZ. Disease in adolescents. A 3-year longitudinal study. J Periodontol. 1991; 62: 370-6.
• ²
  Ickenstein GW, Klotz JM, Langohr HD. Kopfschmerz bei Polycythaemia vera. Schmerz. 1999; 13: 279-82.
• ³
  Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004; 34: 9-21.
• ⁴
  Armitage GC. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000. 2010; 53: 70-88.
• ⁵
  Jardim Jr EG, Bosco JMD, Lopes AM, Landucci LF, Jardim ECG, Carneiro SRS. Occurrence of Actinobacillus actinomycetemcomitans in patients with chronic periodontitis, aggressive periodontitis, healthy subjects and children with gingivitis in two cities of the state of São Paulo, Brazil. J Appl Oral Sci. 2006; 14: 153-6.
• ⁶
  Shaddox LM, Huang H, Lin T, Hou W, Harrison PL, Aukhil I, et al. Microbiological characterization in children with aggressive periodontitis. J Dent Res. 2012; 91: 927-33.
• ⁷
  Lamell CW, Griffen AL, McClellan DL, Leys EJ. Acquisition and colonization stability of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in children. J Clin Microbiol. 2000; 38: 1196-9.
• ⁸
  Fine DH, Markowitz K, Furgang D, Velliyagounder K. Aggregatibacter actinomycetemcomitans as an early colonizer of oral tissues: epithelium as a reservoir? J Clin Microbiol. 2010; 48: 4464-73.
• ⁹
  Henderson B, Ward JM, Ready D. Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periodontopathogen? Periodontol 2000. 2010; 54: 78-105.
• ¹⁰
  Emilson CG. Susceptibility of various microorganisms to chlorhexidine. Scand J Dent Res. 1977; 85: 255-65.
• ¹¹
  Perinetti G, Paolantonio M, Cordella C, Ercole DS, Serra E, Clinical PR. Clinical and microbiological effects of subgingival administration of two active gels on persistent pockets of chronic periodontitis patients. J Clin Periodontol. 2004; 31: 273-81.
• ¹²
  Sekino S, Ramberg P, Uzel NG, Socransky S, Lindhe J. The effect of a chlorhexidine regimen on de novo plaque formation. J Clin Periodontol. 2004; 31: 609-14.
• ¹³
  Löe H, Schiott CR. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodontal Res. 1970; 5: 79-83.
• ¹⁴
  Francis JR, Hunter B, Addy M. A comparison of three delivery methods of chlorhexidine in handicapped children. I. Effects on plaque, gingivitis, and toothstaining. J Periodontol. 1987; 58: 451-5.
• ¹⁵
  Vinholis AH, Figueiredo LC, Marcantonio Júnior E, Marcantonio RA, Salvador SL, Goissis G. Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz Dent J. 2001; 12: 209-13.
• ¹⁶
  Slot DE, Rosema NAM, Hennequin-Hoenderdos NL, Versteeg PA, van der Velden U, van der Weijden GA. The effect of 1% chlorhexidine gel and 0.12% dentifrice gel on plaque accumulation: a 3-day non-brushing model. Int J Dent Hyg. 2010; 8: 294-300.
• ¹⁷
  Quirynen M, Mongardini C, Pauwels M, Bollen CML, van Eldere J, van Steenbergh D. One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. II. Long-term impact on microbial load. J Periodontol. 1999; 70: 646-56.
• ¹⁸
  Ramsey MM, Whiteley M. Polymicrobial interactions stimulate resistance to host innate immunity through metabolite perception. Proc Natl Acad Sci USA. 2009; 106: 1578-83.
• ¹⁹
  De Soete M, Dekeyser C, Pauwels M, Teughels W, van Steenberghe D, Quirynen M. Increase in cariogenic bacteria after initial periodontal therapy. J Dent Res. 2005; 84: 48-53.
• ²⁰
  Mayorga-fayad I, Lafaurie GI, Contreras A, Castillo DM, Barón A, Aya M del R. Microflora subgingival en periodontitis crónica y agresiva en Bogotá, Colombia: un acercamiento epidemiológico. Biomedica. 2007; 27: 21-33.
• ²¹
  Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963; 21: 533-51.
• ²²
  Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol. 1970; 41: 41-3.
• ²³
  Umeda M, Contreras A, Chen C, Bakker I, Slots J. The utility of whole saliva to detect the oral presence of periodontopathic bacteria. J Periodontol. 1998; 69: 828-33.
• ²⁴
  Price RR, Viscount HB, Stanley MC, Leung KP. Targeted profiling of oral bacteria in human saliva and in vitro biofilms with quantitative real-time PCR. Biofouling. 2007; 23: 203-13.
• ²⁵
  Atieh MA. Accuracy of real-time polymerase chain reaction versus anaerobic culture in detection of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: a meta-analysis. J Periodontol. 2008; 79: 1620-9.
• ²⁶
  Berchier CE, Slot DE, van der Weijden GA. The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. J Clin Periodontol. 2010; 37: 829-39.
• ²⁷
  Keijser BJF, Zaura E, Huse SM, van der Vossen JMBM, Schuren FHJ, Montijn RC, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res. 2008; 87: 1016-20.
• ²⁸
  Filoche SK, Soma D, van Bekkum M, Sissons CH. Plaques from different individuals yield different microbiota responses to oral-antiseptic treatment. FEMS Immunol Med Microbiol. 2008; 54: 27-36.
• ²⁹
  Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J Dent Res. 2009; 88: 982-90.

Publication Dates

• Publication in this collection
  19 July 2013
• Date of issue
  June 2013

History

• Received
  20 Mar 2013
• Accepted
  25 June 2013